The SUMO-specific Protease SENP5 is Required for Cell Division
Overview
Affiliations
Posttranslational modification of substrates by the small ubiquitin-like modifier, SUMO, regulates diverse biological processes, including transcription, DNA repair, nucleocytoplasmic trafficking, and chromosome segregation. SUMOylation is reversible, and several mammalian homologs of the yeast SUMO-specific protease Ulp1, termed SENPs, have been identified. We demonstrate here that SENP5, a previously uncharacterized Ulp1 homolog, has SUMO C-terminal hydrolase and SUMO isopeptidase activities. In contrast to other SENPs, the C-terminal catalytic domain of SENP5 preferentially processed SUMO-3 compared to SUMO-1 precursors and preferentially removed SUMO-2 and SUMO-3 from SUMO-modified RanGAP1 in vitro. In cotransfection assays, SENP5 preferentially reduced high-molecular-weight conjugates of SUMO-2 compared to SUMO-1 in vivo. Full-length SENP5 localized to the nucleolus. Deletion of the noncatalytic N-terminal domain led to loss of nucleolar localization and increased de-SUMOylation activity in vivo. Knockdown of SENP5 by RNA interference resulted in increased levels of SUMO-1 and SUMO-2/3 conjugates, inhibition of cell proliferation, defects in nuclear morphology, and appearance of binucleate cells, revealing an essential role for SENP5 in mitosis and/or cytokinesis. These findings establish SENP5 as a SUMO-specific protease required for cell division and suggest that mechanisms involving both the catalytic and noncatalytic domains determine the distinct substrate specificities of the mammalian SUMO-specific proteases.
Zhang X, Ding T, Yang F, Zhang J, Xu H, Bai Y Nat Commun. 2024; 15(1):9068.
PMID: 39433793 PMC: 11494105. DOI: 10.1038/s41467-024-53493-x.
Exploring potential targets for natural product therapy of DN: the role of SUMOylation.
Wang J, Zhang R, Wu C, Wang L, Liu P, Li P Front Pharmacol. 2024; 15:1432724.
PMID: 39431155 PMC: 11486755. DOI: 10.3389/fphar.2024.1432724.
Disruption of cyclin D1 degradation leads to the development of mantle cell lymphoma.
Lu K, Zhang M, Qin H, Shen S, Song H, Jiang H Acta Pharm Sin B. 2024; 14(7):2977-2991.
PMID: 39027231 PMC: 11252481. DOI: 10.1016/j.apsb.2024.03.013.
Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells.
Huang C, Yang T, Lin K J Biomed Sci. 2024; 31(1):16.
PMID: 38280996 PMC: 10821541. DOI: 10.1186/s12929-024-01003-y.
Liu T, Wang H, Chen Y, Wan Z, Du Z, Shen H J Exp Clin Cancer Res. 2023; 42(1):234.
PMID: 37684630 PMC: 10486113. DOI: 10.1186/s13046-023-02789-9.